Mazor Robotics (NSDQ:MZOR) today released preliminary sales data for its 3rd quarter, with purchase orders for 25 of its systems, including pre-orders for its Mazor X robotic spinal system, and revenue of $7.5 million. The company’s Mazor X robotic spinal surgery system is designed to combine analytical tools, precision guidance, optical tracking and intra-operative verification into a single, […]
mazorrobotics
Mazor X unveiling triggers another $20m from Medtronic
Mazor Robotics (NSDQ:MZOR) said today that the unveiling last month of its Mazor X robot-assisted spine surgery platform triggered the 2nd step in a 3-stage equity deal with Medtronic (NYSE:MDT). Medtronic paid $20 million for a 3.4% stake in Mazor at $21.84 apiece, the trailing 20-day average for MZOR shares, the Caesarea, Israel-based company said. It’s part of a 2-stage deal […]
Mazor Q2 tops The Street in EPS, falls short of rev
Mazor Robotics (NSDQ:MZOR) shares rose today after releasing 2nd quarter earnings that put the company above The Street’s expectations for earnings per share, but slightly behind on revenue. The company said it sold a total of 11 Renaissance surgical robotic systems, with 6 installed in the U.S. and 2 systems which included brane modules during the […]
Mazor touts studies showing advantage of robotic assistance in MIS spinal procedures
Mazor Robotics (NSDQ:MZOR) said today it is releasing data from 2 new studies touting the benefits of robotic assistance and surgical guidance with its Renaissance device during minimally invasive spinal surgery procedures. The company said it presented t the data at the 23rd International Meeting on Advanced Spine Techniques in Washington, D.C. “These studies validate the clinical and economic […]
Mazor unveils Mazor X robotic spinal surgery platform
Mazor Robotics (NSDQ:MZOR) today unveiled its Mazor X robotic spinal surgery system, designed to combine analytical tools, precision guidance, optical tracking and intra-operative verification into a single, spinal surgical aid system. The Mazor X is slated to launch during the North American Spine Society’s annual meeting in Boston in October, the Israeli company said. “What we […]
Mazor Robotics inks $42m deal with Medtronic
Mazor Robotics (NSDQ:MZOR) said today that it inked a 2-phase deal with Medtronic (NYSE:MDT) for its robot-assisted spine surgery technology that includes a co-promotion agreement and an equity investment that could see Medtronic wind up with a 15% stake in the Israeli company for as much as $42 million. Caesarea, Israel-based Mazor said the 1st phase of […]
Mazor jumps on Q4, FY 2015 prelim release
Mazor Robotics (NSDQ:MZOR) today reported preliminary results for the 4th quarter and full fiscal year 2015, topping analysts estimates for revenue in both cases and sending shares up over 8%. The company reported record sales for its Renaissance robotic system in the 4th quarter of 2015, dealing out 12 of the devices, split mostly between the U.S. […]
NASS 2015 Roundup: Spine trends stabilizing, new fields taking center stage
The spinal med device market appears to be stabilizing with growth in 3 key areas, according to a letter to investors published this week from Leerink Partner’s Richard Newitter, who attended the North American Spine Society’s annual meeting in Chicago last week. Newitter said the meeting was “neutral-to-positive” for firms in the spinal market, and said […]
Mazor Robotics halves Q2 losses on 74% sales surge
Mazor Robotics (NSDQ:MZOR) cut its 2nd-quarter losses by 50% on sales growth of nearly 74%, selling 7 of its Renaissance robot-assisted surgery platforms during the quarter. Caesarea, Israel-based Mazor said it also sold a system upgrade during the 3 months ended June 30. The company posted losses of -$2.1 million, or -10¢ per share, on sales […]
New JenaValve CEO is Boston Scientific vet Carr-Brendel | Personnel Moves
JenaValve said this week that it tapped Victoria Carr-Brendel, former general manager of Boston Scientific‘s (NYSE:BSX) Bayer Interventional business, as its new chief executive officer. Carr-Brendel will replace Jan Keltjens, who served as interim CEO of the transcatheter aortic valve repair-focused company since January 2015. Keltjens will remain with the company as chairman of the board, JenaValve said. […]